Search clinical trials for: KU-0059436

Total 4784 results

University of Washington
National Cancer Institute (NCI); AstraZeneca

Completed

Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer

Castration-Resistant Prostate Carcinoma | Prostate Adenocarcinoma

United States
Merck Sharp & Dohme LLC

Active, not recruiting

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

Carcinoma, Non-Small-Cell Lung | Lung Neoplasms

Poland, Romania, Ukraine, Chile, Canada, United States, Argentina, China, Czechia, Estonia, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Mexico, Norway, Peru, Russian Federation, Spain, Thailand, Turkey, United...
National Cancer Institute (NCI)

Active, not recruiting

Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer

Ovarian Endometrioid Adenocarcinoma | Fallopian Tube Carcinoma | Triple-Negative Breast Carcinoma | Ovarian Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Ovarian High Grade Serous Adenocarcinoma | Ovarian Serous Surface Papillary Adenocarcinoma

United States
National Cancer Institute (NCI)

Withdrawn

Olaparib and Alpelisib for Treatment of Metastatic Breast Cancer, A ComboMATCH Treatment Trial

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Unresectable HER2-Negative Breast Carcinoma
National Cancer Institute (NCI)

Active, not recruiting

Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma

Recurrent Glioblastoma

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Terminated

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Primary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditions

United States
OHSU Knight Cancer Institute
Genentech, Inc.; Oregon Health and Science University

Withdrawn

SMMART Adaptive Clinical Treatment (ACT) Trial

Anatomic Stage III Breast Cancer AJCC v8 | Recurrent Ovarian Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Recurrent... and other conditions

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery

BRCA1 Gene Mutation | BRCA2 Gene Mutation | Primary Peritoneal High Grade Serous Adenocarcinoma | Stage III Fallopian Tube Cancer AJCC v8 | Stage III Ovarian Cancer AJCC v8 | Stage III Primary Peritoneal Cancer AJCC v8 | Stage IIIA Fallopian Tube Cancer AJCC v8 | Stage IIIA Ovarian Cancer AJCC v8 | Stage... and other conditions

United States
National Cancer Institute (NCI)

Completed

Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer

Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Recurrent Breast Carcinoma | Metastatic Triple-Negative Breast Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Recurrent... and other conditions

United States
OHSU Knight Cancer Institute
Oregon Health and Science University; Prospect Creek Foundation

Completed

Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma

United States
Seoul National University Hospital
Samsung Medical Center; Seoul National University Bundang Hospital

Unknown

Evaluate the Efficacy and Safety of Prevention of Infection Foley Catheter as Compared to Conventional Foley Catheter

Radical Cystectomy | Urological Disease

Korea, Republic of
AstraZeneca
KuDOS Pharmaceuticals Limited

Completed

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Topotecan

Malignant Solid Tumors

United Kingdom
University of California, San Francisco

Recruiting

Hypertension in Young Adults Trial

Hypertension

United States
University of Luebeck

Completed

Study of Immunoadsorption to Treat Severe Atopical Dermatitis Associated With Excessively High Serum IgE Levels

Dermatitis, Atopic

Germany
Universitair Ziekenhuis Brussel

Completed

Advance Care Planning Among Older People From Moroccon Origin in Belgium

Advance Care Planning | Ethnic Minorities | Moroccans | Advance Medical Directives | Muslims | Living Will

Belgium
KU Leuven

Recruiting

Validity and Reliability of Sensorimotor Processing Paradigm

Stroke

Belgium
KU Leuven

Recruiting

Neurofeedback-Assisted Mindfulness Techniques to Reduce Symptoms of Mental Distress (ComBiNe)

Stress

Belgium
Hilde Feys
Hasselt University; ETH Zurich; Curtin University

Recruiting

Upper Limb Somatosensory Discrimination Therapy and Dose-matched Motor Therapy in Children and Adolescents With Unilateral Cerebral Palsy

Hemiplegic Cerebral Palsy | Cerebral Palsy, Spastic

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

PEA in Functional Dyspepsia

Dyspepsia and Other Specified Disorders of Function of Stomach

Belgium
KU Leuven

Recruiting

The Effect of Foot Core Exercises or Foot Orthotics in Symptomatic Flexible Flatfoot

Flatfoot, Flexible

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

The Effect of a Low FODMAP Diet in Functional Dyspepsia Patients With Meal Related Symptoms (FFD)

Functional Dyspepsia | FODMAP Diet

Belgium
KU Leuven

Enrolling by invitation

The Impact of Grand Tour Cycling on Sleep and the Hematological and Metabolomic Profile in World-class Cyclists

Overreaching

Belgium
KU Leuven

Completed

Characterization of Complex Pulse Shapes in Deep Brain Stimulation for Movement Disorders Using EEG and Local Field Potential Recordings (CHANNEL DBS)

Parkinson Disease | Essential Tremor

Belgium
Jorio Mascheroni

Completed

Effect of Simulation-based Procedure Training for Novice Cardiac Device Implanters Towards Implant Proficiency (IMPROF)

Knowledge, Attitudes, Practice

Belgium
KU Leuven

Enrolling by invitation

BIC: Evaluation of the Current Care Processes for Stroke Care in Flemish Hospitals

Stroke, Ischemic

Belgium
KU Leuven
Kom Op Tegen Kanker

Enrolling by invitation

Breakthrough Improvement Collaborative for ColoRectal Cancer (BIC4CRC) (BIC4CRC)

Colorectal Cancer

Belgium
European Pathway Association
Universitaire Ziekenhuizen KU Leuven; KU Leuven

Completed

CP4ACS - Delphi Study to Determine Appropriateness of STEMI Quality Indicators in Belgium

STEMI | Quality Indicators

Belgium
Jozef Stefan Institute
KU Leuven

Completed

Effect of Oral Ketone and Sodium Bicarbonate Administration During Endurance Exercise in Hypoxia

Hypoxia | Exercise

Belgium
KU Leuven

Completed

Influence of Oxytocin on Approach-avoidance Tendencies to Social and Non-social Stimuli

Basic Science

Belgium
KU Leuven
Universitaire Ziekenhuizen KU Leuven

Unknown

A Mobile Mindfulness Programme for Individuals/Couples Experiencing Fertility Problems (MoMiFer)

Infertility

Belgium
KU Leuven

Completed

The Trans-cutaneous Effects on Physiological Tremor Entertainment During tACS

Tremor, Limb

Belgium
KU Leuven

Completed

Observational Feasibility Study of Home-based Training With Therabands in PAD-patients

Intermittent Claudication | Peripheral Artery Disease

Belgium
KU Leuven
Research Foundation Flanders

Completed

Influence of Oxytocin on Resting State Neurophysiological Measures

Oxytocin

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

PRObiotic and Stress-related PERmeability (ProSPer)

Permeability; Increased

Belgium
KU Leuven

Completed

Exploratory Study to Inventory Opportunities to Optimize Continuity of Pharmacotherapy at Hospital Discharge

Patient Discharge | Pharmacist | Physicians, Primary Care

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

A Measurement of Knee Osteoarthritis Usual Care

Osteoarthritis, Knee | Guideline Adherence | Quality Indicators, Health Care

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Study on the Impact of Ocular Anesthetic Procedures in Ocular Blood Flow

Open Angle Glaucoma

Belgium
Universitaire Ziekenhuizen KU Leuven
Ministry of the Flemish Community

Completed

A stAPP to a Healthier Lifestyle

Sedentary Lifestyle

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Study on Ocular Blood Flow and the Orbital Cerebrospinal Fluid Pressure in Glaucoma

Open Angle Glaucoma | Normal Tension Glaucoma

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Correlation of Orbital Cerebrospinal Fluid Pressure and Retinal Venous Outflow in Primary Open-angle Glaucoma

Primary Open Angle Glaucoma | Normal Tension Glaucoma

Belgium
Trakya University
Koç University

Completed

The Effect of "Quantum-Touch" on Pain, Fear, and Anxiety of the Children

Pain, Acute | Child Behavior | Anxiety and Fear | Venipuncture Site Reaction | Quantum

Turkey
Cambridge University Hospitals NHS Foundation Trust
National Institute for Health Research, United Kingdom

Not yet recruiting

Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer

Pancreatic Cancer
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
National Cancer Institute (NCI)

Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Anatomic Stage III Breast Cancer AJCC v8 | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid... and other conditions

United States, Puerto Rico
National Cancer Institute (NCI)

Recruiting

Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer

Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Unresectable Pancreatic Carcinoma | Locally Advanced Pancreatic Carcinoma

United States, Canada
National Cancer Institute (NCI)

Recruiting

Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer

Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma

United States
National Cancer Institute (NCI)

Recruiting

Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations

Pancreatic Adenocarcinoma | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Adenocarcinoma

United States
National Cancer Institute (NCI)

Recruiting

Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer

Metastatic Adrenal Gland Pheochromocytoma | Metastatic Paraganglioma | Unresectable Adrenal Gland Pheochromocytoma | Unresectable Paraganglioma | Advanced Adrenal Gland Pheochromocytoma | Advanced Paraganglioma | Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8 | Stage...

United States
OHSU Knight Cancer Institute
AstraZeneca; Oregon Health and Science University

Recruiting

Olaparib in Combination With Either Durvalumab, Selumetinib, or Capivasertib or Ceralasertib Alone in Treating Patients With Metastatic Triple Negative Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma

United States
Rahul Aggarwal
AstraZeneca

Recruiting

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Clear Cell Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Endometrial Cancer | Stage III Renal Cell Cancer | Locally Advanced Malignant Solid Neoplasm | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Metastatic Malignant Solid Neoplasm | Metastatic Urothelial Carcinoma | Stage IV... and other conditions

United States

Search clinical trials for: KU-0059436

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations